- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/48 - Hydrolases (3) acting on peptide bonds (3.4)
Patent holdings for IPC class A61K 38/48
Total number of patents in this class: 3970
10-year publication summary
|
324
|
312
|
337
|
375
|
308
|
343
|
303
|
319
|
281
|
181
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2347 |
144 |
| Ipsen Biopharm Limited | 263 |
68 |
| MERZ PHARMA GmbH & CO. KGaA | 612 |
64 |
| Talengen International Limited | 79 |
60 |
| Revance Therapeutics, Inc. | 124 |
39 |
| The Regents of the University of California | 19961 |
38 |
| Baxter International Inc. | 2405 |
36 |
| Curemark, LLC | 74 |
36 |
| Modernatx, Inc. | 1257 |
36 |
| Bioverativ Therapeutics Inc. | 213 |
35 |
| Translate bio, Inc. | 416 |
33 |
| The Children's Hospital of Philadelphia | 787 |
32 |
| Baxter Healthcare S.A. | 1833 |
30 |
| HANSA Biopharma AB | 67 |
30 |
| Penland Foundation | 39 |
30 |
| Takeda Pharmaceutical Company Limited | 2708 |
28 |
| Omrix Biopharmaceuticals Ltd. | 153 |
26 |
| Alexion Pharmaceuticals, Inc. | 638 |
25 |
| Talengen Institute of Life Sciences Co., Ltd. | 28 |
25 |
| Smith & Nephew, Inc. | 2668 |
24 |
| Other owners | 3131 |